Yuka Morikawa Selected Research

Yuka Morikawa Research Topics

3	Heart Failure 01/2022 - 11/2013
2	Hypertension (High Blood Pressure) 11/2020 - 01/2016
1	Tetralogy of Fallot (Fallot Tetralogy) 01/2022
1	Hypoplastic Left Heart Syndrome 01/2022
1	Disease Progression 01/2022
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 11/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2020
1	Albuminuria 11/2020
1	Atrial Fibrillation 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Myocardial Infarction 10/2017
1	Infarction (Infarctions) 10/2017
1	Hypertrophy 01/2016
1	Inflammation (Inflammations) 01/2016
1	Proteinuria 01/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Muscular Dystrophies (Muscular Dystrophy) 05/2015
1	Heart Diseases (Heart Disease) 11/2013
1	Fistula 04/2011
1	Dyspnea (Shortness of Breath) 04/2011
1	Neoplasms (Cancer) 04/2011
1	Atherosclerosis 02/2003

2	esaxerenoneIBA 11/2020 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 11/2013
1	RNA (Ribonucleic Acid)IBA 01/2022
1	olmesartanIBA 11/2020
1	Angiotensin Receptor AntagonistsIBA 11/2020
1	AlbuminsIBA 11/2020
1	CreatinineIBA 11/2020
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 11/2020
1	Antihypertensive Agents (Antihypertensives)IBA 11/2020
1	CollagenIBA 01/2018
1	ferric chlorideIBA 01/2018
1	Adenosine Diphosphate (ADP)IBA 01/2018
1	P-SelectinIBA 01/2018
1	Phosphotransferases (Kinase)IBA 10/2017
1	Small Interfering RNA (siRNA)IBA 10/2017
1	Messenger RNA (mRNA)IBA 01/2016
1	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2016
1	DystrophinIBA 05/2015
1	Glycoproteins (Glycoprotein)IBA 05/2015
1	AntagomirsIBA 11/2013
1	Basic Helix-Loop-Helix Transcription FactorsIBA 11/2013
1	MicroRNAs (MicroRNA)IBA 11/2013
1	CyanoacrylatesIBA 04/2011
1	T0901317IBA 02/2003
1	LDL Receptors (LDL Receptor)IBA 02/2003
1	LigandsIBA 02/2003
1	Liver X ReceptorsIBA 02/2003